1-9 of 9
Authors: Sara Byron
Journal Article
DIPG-31. Prognostic and predictive biomarkers of response in children and young adults with H3K27M-altered diffuse intrinsic pontine glioma: results from a multi-center, interventional clinical trial (PNOC003) Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i25, https://doi.org/10.1093/neuonc/noac079.088
Published: 03 June 2022
Journal Article
DIPG-76. PNOC-003: PRECISION MEDICINE TRIAL FOR CHILDREN WITH DIFFUSES INTRINSIC PONTINE GLIOMA: PRELIMINARY EXPERIENCE WITH MULTI-AGENT PERSONALIZED THERAPY RECOMMENDATIONS Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i64, https://doi.org/10.1093/neuonc/noy059.168
Published: 22 June 2018
Journal Article
DIPG-40. PNOC-003: PRECISION MEDICINE TRIAL FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA Free
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv14, https://doi.org/10.1093/neuonc/nox083.055
Published: 31 May 2017
Journal Article
MPTH-01. ARE MUTATIONS IN MISMATCH REPAIR (MMR) GENES OUR NEXT BIOMARKER OF ALKYLATING AGENT INDUCED HYPERMUTATOR PHENOTYPE? PRELIMINARY RESULTS FROM THE IVY PRECISION TRIAL Free
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi105, https://doi.org/10.1093/neuonc/now212.440
Published: 07 November 2016
Journal Article
HG-115PRECISION MEDICINE APPROACH FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA Free
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii75, https://doi.org/10.1093/neuonc/now073.111
Published: 30 May 2016
Journal Article
BM-15TARGETING MEK IS A NOVEL AND EFFECTIVE TREATMENT STRATEGY OF LUNG CNS METASTASIS Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v35, https://doi.org/10.1093/neuonc/nou240.15
Published: 01 November 2014
Journal Article
GE-03GENOMIC CHARACTERIZATION OF SURVIVAL OUTLIERS IN GLIOBLASTOMA MULTIFORME Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v96, https://doi.org/10.1093/neuonc/nou256.3
Published: 01 November 2014
Journal Article
GE-19GENOMICS GUIDED THERAPEUTIC APPROACH FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME (GBM) USING NEXT GENERATION SEQUENCING (NGS) TECHNOLOGIES Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v100, https://doi.org/10.1093/neuonc/nou256.18
Published: 01 November 2014
Journal Article
PL-03FEASIBILITY OF GENOMICS-ENABLED THERAPY FOR PEDIATRIC HIGH-GRADE GLIOMAS AND DIFFUSE PONTINE GLIOMAS Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v168, https://doi.org/10.1093/neuonc/nou267.3
Published: 01 November 2014
